Longitudinal Measurement and Hierarchical Classification Framework for the Prediction of Alzheimer\u27s Disease by Huang, Meiyan et al.
University of Kentucky
UKnowledge
Neurology Faculty Publications Neurology
1-12-2017
Longitudinal Measurement and Hierarchical
Classification Framework for the Prediction of
Alzheimer's Disease
Meiyan Huang
Southern Medical University, China
Wei Yang
Southern Medical University, China
Qianjin Feng
Southern Medical University, China
Wufan Chen
Southern Medical University, China
Michael Weiner
University of California - San Francisco
See next page for additional authors
Right click to open a feedback form in a new tab to let us know how this document benefits you.Follow this and additional works at: https://uknowledge.uky.edu/neur logy_facpub
Part of the Diagnosis Commons, Diseases Commons, Longitudinal Data Analysis and Time
Series Commons, and the Neurology Commons
This Article is brought to you for free and open access by the Neurology at UKnowledge. It has been accepted for inclusion in Neurology Faculty
Publications by an authorized administrator of UKnowledge. For more information, please contact UKnowledge@lsv.uky.edu.
Repository Citation
Huang, Meiyan; Yang, Wei; Feng, Qianjin; Chen, Wufan; Weiner, Michael; Aisen, Paul; Petersen, Ronald; Jack, Clifford R. Jr.; Jagust,
William; Trojanowki, John; Toga, Arthur W.; Beckett, Laurel; Green, Robert C.; Saykin, Andrew; Morris, John; Shaw, Leslie M.; Kaye,
Jeffrey; Quinn, Joseph; Silbert, Lisa; Lind, Betty; Carter, Raina; Dolen, Sara; Schneider, Lon S.; Pawluczyk, Sonia; Beccera, Mauricio;
Teodoro, Liberty; Spann, Bryan; Brewer, James; Vanderswag, Helen; Fleisher, Adam; Smith, Charles D.; Jicha, Greg A.; Hardy, Peter
A.; Sinha, Partha; Oates, Elizabeth; and Conrad, Gary, "Longitudinal Measurement and Hierarchical Classification Framework for the
Prediction of Alzheimer's Disease" (2017). Neurology Faculty Publications. 18.
https://uknowledge.uky.edu/neurology_facpub/18
Authors
Meiyan Huang, Wei Yang, Qianjin Feng, Wufan Chen, Michael Weiner, Paul Aisen, Ronald Petersen, Clifford
R. Jack Jr., William Jagust, John Trojanowki, Arthur W. Toga, Laurel Beckett, Robert C. Green, Andrew
Saykin, John Morris, Leslie M. Shaw, Jeffrey Kaye, Joseph Quinn, Lisa Silbert, Betty Lind, Raina Carter, Sara
Dolen, Lon S. Schneider, Sonia Pawluczyk, Mauricio Beccera, Liberty Teodoro, Bryan Spann, James Brewer,
Helen Vanderswag, Adam Fleisher, Charles D. Smith, Greg A. Jicha, Peter A. Hardy, Partha Sinha, Elizabeth
Oates, and Gary Conrad
Longitudinal Measurement and Hierarchical Classification Framework for the Prediction of Alzheimer's Disease
Notes/Citation Information
Published in Scientific Reports, v. 7, article no. 39880, p. 1-13.
© The Author(s) 2017
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other
third party material in this article are included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the Creative Commons license, users will
need to obtain permission from the license holder to reproduce the material. To view a copy of this license,
visit http://creativecommons.org/licenses/by/4.0/.
Due to the large number of authors, only the first 30 and the authors affiliated with the University of Kentucky
are listed in the author section above. For the complete list of authors, please download this article or visit:
https://doi.org/10.1038/srep39880
This group of authors is collectively known as the Alzheimer’s Disease Neuroimaging Initiative.
Digital Object Identifier (DOI)
https://doi.org/10.1038/srep39880
This article is available at UKnowledge: https://uknowledge.uky.edu/neurology_facpub/18
1Scientific RepoRts | 7:39880 | DOI: 10.1038/srep39880
www.nature.com/scientificreports
Longitudinal measurement 
and hierarchical classification 
framework for the prediction of 
Alzheimer’s disease
Meiyan Huang1, Wei Yang1, Qianjin Feng1, Wufan Chen1 & the Alzheimer’s Disease 
Neuroimaging Initiative#
Accurate prediction of Alzheimer’s disease (AD) is important for the early diagnosis and treatment of 
this condition. Mild cognitive impairment (MCI) is an early stage of AD. Therefore, patients with MCI 
who are at high risk of fully developing AD should be identified to accurately predict AD. However, 
the relationship between brain images and AD is difficult to construct because of the complex 
characteristics of neuroimaging data. To address this problem, we present a longitudinal measurement 
of MCI brain images and a hierarchical classification method for AD prediction. Longitudinal images 
obtained from individuals with MCI were investigated to acquire important information on the 
longitudinal changes, which can be used to classify MCI subjects as either MCI conversion (MCIc) or MCI 
non-conversion (MCInc) individuals. Moreover, a hierarchical framework was introduced to the classifier 
to manage high feature dimensionality issues and incorporate spatial information for improving the 
prediction accuracy. The proposed method was evaluated using 131 patients with MCI (70 MCIc and 61 
MCInc) based on MRI scans taken at different time points. Results showed that the proposed method 
achieved 79.4% accuracy for the classification of MCIc versus MCInc, thereby demonstrating very 
promising performance for AD prediction.
Alzheimer’s disease (AD) is characterized by the progressive impairment of cognitive and memory functions 
and is the most common form of dementia in elderly people. As the life expectancy increases, the number of AD 
patients increases accordingly, thereby causing a heavy socioeconomic burden1,2. Mild cognitive impairment 
(MCI) is a prodromal stage of AD; existing studies have suggested that individuals with amnestic MCI tend to 
progress to probable AD at a rate of approximately 10% to 15% per year1,3. Generally, patients with MCI who con-
vert to AD after some time are called MCI converters (MCIc), whereas others who never convert to AD or even 
revert to a normal status are called MCI non-converters (MCInc). The classification of MCInc and MCIc is stud-
ied because of its importance in the early prediction of AD. Considering the limited period for which the sympto-
matic treatments are effective, patients with MCI who are at high risk of fully developing AD should be identified.
Recent studies showed that MRI can contribute significant progress to understand the neural changes related 
to AD and other diseases. Moreover, MRI data provide some brain structure information; this information can 
be used to identify the anatomical differences between populations of AD patients and normal controls (NC) and 
assist in the diagnosis and evaluation of MCI progression4,5. Generally, most MRI-based classification methods 
consist of two major steps: (1) feature extraction and selection and (2) classifier learning. Basing on the type of 
features extracted from MRI, the MCInc/MCIc classification methods can be divided into three categories: the 
voxel-based approach6–9, the vertex-based approach1,10,11, and the region of interest (ROI)-based approach12–15.
The vertex-based approach can be used to obtain information regarding the conversion from MCI to AD by 
using cortical thickness, sulcal depth, or cortical surface area as features. Although crucial disease progression infor-
mation can be acquired through the vertex-based approach, this method depends on the accuracy of the surface 
registration1. The ROI-based approach usually employs nonlinear registration to register a brain MRI image to a 
structurally or functionally predefined brain region template before extracting representative features from each 
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region. Although the ROI-based approach can significantly reduce the feature dimensionality, the features extracted 
from ROIs are very coarse and cannot reflect small or subtle changes associated with the brain diseases16. In the 
voxel-based approach, the features are defined at the level of the MRI voxel, which is simple and intuitive in terms 
of the interpretation of the results. However, the main limitations of the voxel-based approach are the high dimen-
sionality of feature vectors and the lack of spatial information16. On one hand, the high dimensionality of feature 
vectors often leads to low performance attributed to the “curse of dimensionality”2. To address this problem, feature 
selection is typically performed to reduce feature dimensionality and eliminate the redundant features. On the other 
hand, AD often affects spatially contiguous regions instead of isolated voxels. Thus, the local spatial contiguity of the 
selected discriminative features (voxels) should be carefully considered during feature selection or classification2,5,16.
Recently, several longitudinal neuroimaging studies have collected a rich set of longitudinal data to better under-
stand the progress of neuropsychiatric and neurodegenerative diseases or normal brain development3,17–22. The pre-
dictive value of early brain developmental trajectories should be studied for later brain and cognitive development 
and disease progression18,19. Therefore, the longitudinal changes in MRI measures may be a crucial factor in the 
prediction of future conversion from MCI to AD3,7,20,23–25. In the group-based approaches, longitudinal data have 
already been used for measuring longitudinal changes of the brain; until very recently, only a few researchers started 
to use longitudinal data for individual-based MCInc/MCIc classification3,7,20,26,27. Li et al.20 investigated the longitu-
dinal cortical thickness changes of 75 MCI subjects to distinguish MCIc from MCInc. Moreover, Zhang et al.3 pro-
posed an AD prediction method with ROI-based features from longitudinal data. The experiments were performed 
on 88 MCI subjects, and the results shown that the performance of their method with longitudinal data was better 
than that with baseline visit data3. Despite these efforts, extracting discriminative features from longitudinal data for 
the early diagnosis and prediction of AD progression is still challenging and requires more research.
In the present study, a longitudinal measurement-based hierarchical classification (LMHC) method for AD 
prediction is proposed. Specifically, longitudinal images obtained from individuals with MCI were investigated 
to acquire important information on the longitudinal changes that can be used to classify MCI subjects as MCIc 
or MCInc individuals. From a clinical perspective, an observed trend can show the tendency of an MCI subject 
to become an AD patient or to remain stable. If such trends are dynamically monitored with longitudinal data, 
AD-related changes can be determined; an AD prediction model can be constructed with the longitudinal data. In 
clinical settings, when a new MRI scan of an MCI subject is available, the future medical condition of the MCI subject 
(to develop AD or remain stable) can be predicted with his/her previous MRI scans and the constructed prediction 
model (Fig. 1). Thus, richer information can be extracted from the longitudinal data to help enhance the prediction 
accuracy. From a feature extraction perspective, several studies also suggested that voxel-based morphometry of lon-
gitudinal data can provide useful information regarding AD progression25,28,29. Thus, voxel intensities in MRI images 
from longitudinal data are used as features for classification. From a classifier construction perspective, instead of 
building a single classifier with an optimal subset of features, an ensemble learning method was used in this study to 
improve the generalizability and robustness of individual classifiers. Recently, a hierarchical ensemble classification 
method that combined multilevel classifiers through gradual integration of numerous features from both local brain 
regions and interbrain regions was proposed in refs 16 and 30. Unlike the abovementioned studies, we proposes a 
hierarchical classification method that builds multiple and multilevel classifiers with supervised learning and suitable 
thresholds to address the issues of high feature dimensionality and sensitivity to small changes for more accurate clas-
sification of MCI. Therefore, we can evaluate the classification abilities of the image features in various brain regions 
and at different levels. The performance of the proposed AD prediction method was tested on 131 patients with MCI 
with MRI scans taken at different time points. Overall, the findings show that the proposed method with longitudinal 
data and the hierarchical classification framework generate promising results for AD prediction.
Materials
Data were downloaded from the Alzheimer’s disease Neuroimaging Initiative (ADNI) database (www.loni.
ucla.edu/ADNI, PI Michael M. Weiner). ADNI was launched in 2003 by the National Institute on Aging (NIA), 
the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Food and Drug Administration 
(FDA), private pharmaceutical companies and non-profit organizations, as a $60 million, 5-year public–private 
partnership. The primary goal of ADNI has been to test whether serial MRI, PET and other biological mark-
ers are useful in clinical trials of MCI and early AD. Determination of sensitive and specific markers of very 
early AD progression is intended to aid researchers and clinicians to develop new treatments and monitor their 
Figure 1. An example using longitudinal data to predict AD conversion. 
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effectiveness, as well as lessen the time and cost of clinical trials. ADNI subjects aged 55 to 90 from over 50 
sites across the US and Canada participated in the research and more detailed information is available at www.
adni-info.org.
T1-weighted MRI images were used in this study. The scanning parameters for the 1.5T MRI images can be 
found in ref. 31. A total of 131 subjects with MCI (70 MCIc and 61 MCInc) from ADNI1 were considered in this 
study. Demographic information of the studied subjects is presented in Table 1. The diagnosis of the 61 MCInc 
subjects was MCI at all available time points (0–48 months). Moreover, the diagnosis of the 70 MCIc subjects was 
MCI at baseline but conversion to AD was reported after baseline within 6, 12, 24, 36, or 48 months, and without 
reversion to MCI or NC at any available follow-up (0–48 months). From the 70 MCIc subjects, 11 subjects were con-
verted to AD within the first 6 months, 28 subjects were converted to AD between the 6 and 12 months follow-up, 17 
subjects were converted to AD between the 12 and 18 months follow-up, 7 subjects were converted to AD between 
the 18 and 24 months follow-up, and the remaining 7 subjects were converted to AD between the 24 and 36 months 
follow-up. The number of MCI subjects who converted from MCI to AD during different time points is displayed 
in Table 2. The MRI scans at the baseline visit, 6, 12, 24, 36, and 48 months were used in the AD prediction when 
available. A longitudinal study usually covers a relatively long period of time in the field of health sciences; some 
individuals almost always miss their scheduled visits or date of observation. Therefore, the sequence of observation 
times may vary across individuals19. The details of subject number at different time points are listed in Table 3.
Methods
Preprocessing. Given that the intensity values in MRI images do not indicate a fixed meaning and widely 
vary within or between subjects, the MRI images were preprocessed with the following steps. First, the N3 
method32 was applied to remove bias field artifacts from the images. Second, a two-step method33 was used to 
normalize the intensity values. Third, all images were spatially normalized to the publicly available ICBM152 
average34 via FLIRT (http://www.fmrib.ox.ac.uk/fsl/). The images were subsequently aligned to a standard tem-
plate space with an image size of 193 × 229 × 193 and a voxel size of 1 mm × 1 mm × 1 mm. Subsequently, the 
non-brain tissues were removed with the skull stripping method proposed in ref. 35. The intensity values were 
normalized again by the following steps. The intensity values for the brain region were calculated at 0.1% and 
99.9% quantiles; both values were used to linearly scale the intensity values of voxels to the range of [0, 100]. 
Finally, for the simplicity of the proposed method, MRI data obtained before the missing time points were used 
as the missing data. For instance, if MRI scans are obtained at baseline visit, 6, 24, and 36 months, then we used 
the MRI scans from the 6 and 36 months as data for the 12 and 48 months, respectively. Thus, the number of time 
points remained the same among all the subjects considered for data collection.
Basic idea of LMHC. In this study, voxel intensities in MRI images were used as features for classification. 
The voxel intensity is high dimensional, which consists of much more voxels (193 × 229 × 193 ≈ 8.53 × 106) than 
the subjects (that is, hundreds at most). If all voxel intensities are used as classification features, the high dimen-
sionality features will likely degrade the classification capability of the classifier. To solve this problem, a common 
strategy used is to select a set of useful voxels and apply a supervised classifier on these voxels to perform clas-
sification. However, an optimal subset of discriminative features is difficult to find by using only a single global 
classifier given that the discriminative features from the high dimensional neuroimaging data may lie in multiple 
low-dimensional feature subspaces2. Moreover, disease-induced structural changes may occur at some relatively 
large regions of the brain36,37. Therefore, the spatial information found in several voxel-grouped local regions 
should be considered to enhance the classification accuracy.
Diagnosis Number Age Gender (M/F) MMSE
MCIc 70 74.26 ± 7.55 42/28 26.46 ± 1.76
MCInc 61 75.85 ± 6.49 32/29 27.05 ± 1.78
Table 1.  Demographic information of the studied subjects from the ADNI database.
Time point First 6 m 6–12 m 12–18 m 18–24 m 24–36 m Total
number 11 28 17 7 7 70
Table 2.  Number of MCI subjects who developed to AD during different time points (6 m, 12 m, 18 m, 
24 m, and 36 m represent 6, 12, 24, and 36 months, respectively).
Baseline 6 m 12 m 18 m 24 m 36 m 48 m Total
MCIc 70 61 65 52 52 31 8 339
MCInc 61 55 49 30 27 12 1 235
Total 131 116 114 82 79 43 9 574
Table 3.  Number of MCIc and MCInc subjects at different time points (6 m, 12 m, 18 m, 24 m, 36 m, and 
48 m represent 6, 12, 24, 36, and 48 months, respectively).
www.nature.com/scientificreports/
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To address the abovementioned problems, we proposed a longitudinal measurement-based hierarchical classi-
fication framework that hierarchically combined multiple individual classifiers for more accurate AD prediction. 
Specifically, the logical regression classifier (LRC), which is easily used and trained, was employed to design each 
individual classifier. To select a set of informative voxels, the longitudinal data from different time points (MRI 
data of MCI subjects after the conversion were also included) were used to train each individual classifier. With the 
selected voxel set, a hierarchical classification framework can be built on the selected voxel sites with the longitudinal 
data at time points that are at least 6 months ahead of the conversion. Given that each voxel or region feature defines 
a subspace of the whole brain feature space, each individual classifier can be trained more easily in a much smaller 
subspace, and thereby substantially improving in the dimensionality-to-subject ratio. The accuracy of the final clas-
sification can be further improved by replacing a single classifier with a hierarchical classification framework.
The overall schematic of the proposed classification method is shown in Fig. 2. The method consists of two 
fundamental steps: a voxel selection step that selects a good subset of MRI voxels for AD conversion prediction 
and a classification step that uses a hierarchical framework to make the final prediction. We provide details for 
each step in the following sections.
Selection of significant voxels. For accurate classification, the most useful voxels among all the MRI vox-
els were selected, whereas the noisy ones were excluded. For voxel selection, we used LRC on the longitudinal 
data. Given a training image set, X = {Iij, Li}i=1, …, N, j=1, …, T, for the longitudinal data, the longitudinal feature of a 
voxel site v of the images is represented as = …= =F f f{ } {[ , , ]}v v
n
v v
N
v
n
1
1
1, where N is the subject number, T is the 
number of time points, Li ∈ {0, 1} is the label of the ith image, n is the voxel number, and fv
i is a feature vector 
containing T elements. In this voxel selection step, the longitudinal data from different time points were included 
because the data from MCI to AD status can provide important conversion information on the classification of 
MCIc and MCInc. In addition, the longitudinal feature of each voxel site in the training images was used to learn 
an LRC, and the longitudinal features in the training images were fed to their corresponding classifiers to obtain 
a confident value for each voxel site. The confident values ranged from 0 to 1. Finally, the voxel sites with confident 
values higher than the threshold ts were selected. Specifically, the cost function of LRC on the longitudinal fea-
tures at voxel site v was calculated as
Figure 2. (a) Flowchart and (b) illustration of the proposed LMHC method.
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Given that no closed-form technique can be used to solve for the minimum of J(wv), we used the gradient 
descent method to iteratively optimize eq. (1). For the training image set, X = {Iij, Lt}i=1, …, N, j=1, …, T, and its corre-
sponding longitudinal feature set, = …= =F f f{ } {[ , , ]}v v
n
v v
N
v
n
1
1
1, the classification result of LRC for subject i at 
voxel site v was defined as
= + −w fc 1/(1 exp( )) (2)v
i
v
T
v
i
Thus, the confident value at voxel site v was calculated as
∑= > . ==y c L N1{1{ 0 5} }/ (3)v i
N
v
i
i1
Finally, the significant voxels were selected as Vs = {v|yv > ts}.
Hierarchical classification method. After selecting a set of significant voxels, a hierarchical classification 
framework was constructed on the selected voxel sites of the longitudinal data. In this step, only the longitu-
dinal data at time points that are at least 6 months ahead of the conversion were used because of their impor-
tance in predicting the conversion of MCI in the clinic. In the hierarchical classification framework, a three-level 
classifier was built for forming decisions: voxel, patch, and image levels. For the first-level classifier, a classifier 
was built for each longitudinal feature at every significant voxel site. For the second- and third-level classifi-
ers, the outputs from the lower-level classifiers were fed to the corresponding upper-level classifier (Fig. 2(b)). 
Specifically, for the voxel-level classification, an LRC was independently trained for each significant voxel site 
with the longitudinal feature as input. The output coming from the voxel-level LRC is a confident value, which 
was obtained as the output in the voxel selection step. We selected the confident values higher than the threshold 
th as inputs for the patch-level classifier. To incorporate the spatial information, an image with the original image 
size (193 × 229 × 193) was generated. In this image, the values at the selected voxel sites (that is, voxel sites with 
confident values higher than th) were set according to the corresponding confident values, whereas the rest of 
the values were set to 0. Subsequently, the confident values inside a patch with size w (image values equal to 0 
were excluded) on the image were fed to an LRC for patch-level classification. Finally, the confident value from 
a patch-level classifier with a value higher than th was isolated and fed to the image-level classifier. The output 
obtained from the image-level classifier was the final decision for AD prediction. Notably, the threshold th at dif-
ferent levels shared the same value. Moreover, voxels that were not useful (i.e., p < th) for the classification were 
discarded, and each patch classifier covered various regions of the different brain areas.
Summary of LMHC. To elucidate the concept of LMHC, we provided a pseudo-code for LMHC, as illus-
trated in Algorithm 1.
Algorithm 1. LMHC
Input: Training image set X = {Iij, Lt}i=1, …, N, j=1, …, T and testing image set =
=
{ }x Ij j
t
1
Output: The classification label L of x.
Training stage:
1. Significant voxel selection: A LRC was constructed for each voxel in the brain.
(1)  The longitudinal features, =  …

= ={ }F f f{ } , ,v vn v vN v
n
1
1
1
, were extracted from X with all time point data for all voxels in the brain. An 
LRC was learned with eq. (1) for the longitudinal features at each voxel site.
(2)  The confident values were computed with eqs (2) and (3); the significant voxels with confident values higher than the threshold ts were 
selected: Vs = {v|yv > ts}.
2. Hierarchical classification: A hierarchical classification framework was constructed.
(1)  Voxel-level classification: The longitudinal features, =  …

= ={ }F f f{ } , ,v vn v vN v
n
1
1
1
, were extracted from X with different time point data 
from MCI subjects (only the longitudinal data at time points that are at least 6 months ahead of the conversion were used) at selected 
significant voxel sites. An LRC was developed for each longitudinal feature.
(2)  Patch-level classification: The confident values obtained from the voxel-level classifiers that were higher than the threshold th were 
selected, an image was generated with the selected confident values as image values, and an LRC was learned for the selected confident 
values inside a patch with a size of w on the generated image.
(3)  Image-level classification: For the selection of input, the confident values obtained from the patch-level classifiers that were higher than 
the threshold th. An LRC was learned for all the selected confident values.
Test stage:
1.  The longitudinal features, =  …

= ={ }F f f{ } , ,v vn v vN v
n
1
1
1
, were extracted from x with different time point data from MCI subjects (only 
the longitudinal data at time points that are at least 6 months ahead of the conversion were used) at selected significant voxel sites.
2. Hierarchical classification was performed on the extracted features, and the label L of x was obtained.
www.nature.com/scientificreports/
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Results
Experimental setting. The proposed method was evaluated with two nested cross-validation loops (10-fold 
for each loop)9. Specifically, for the external 10-fold cross-validation, all subject samples were divided into 10 
subsets with the same proportion of each class label. For each run, all samples within one subset were successively 
chosen as the testing set, whereas the remaining samples in the other nine subsets were combined and used as the 
training set for voxel selection and classification. The final classification results were reported as the mean results 
from each run. Moreover, parameter tuning was evaluated with the inner 10-fold cross-validation on the training 
set. In particular, the training set can be further split into a training part and a validation part for each run of 
the external 10-fold cross-validation. By varying the values of the different parameters, the proposed classifier 
was developed using the samples in the training part. The classification results were obtained during validation. 
The parameters with the maximum average classification accuracy during validation were selected. Notably, all 
longitudinal data (MRI data of MCI subjects after the conversion were also included) on a subject were used in 
the training step to select a set of informative voxels. However, given that only NC and MCI data were available in 
practice for AD prediction, the longitudinal data at time points that were at least 6 months ahead of the conver-
sion were used to train hierarchical classifiers. In addition, the longitudinal data at time points that were at least 6 
months ahead of the conversion were used in the validation and testing steps.
In the experiments, four measurement criteria were applied to evaluate the classification performance: sensi-
tivity (SEN), specificity (SPE), accuracy (ACC), and the area under the receiver operating characteristic (ROC) 
curve (AUC). Specifically, the accuracy is the proportion of subjects correctly predicted among all the studied 
subjects. The sensitivity is the proportion of correctly predicted MCIc, whereas the specificity is the proportion 
of correctly predicted MCInc.
Parameter optimization. The parameter settings of the proposed method were carefully considered to 
achieve optimum performance in our experiments. A summary of the parameter settings in the proposed method 
is presented in Table 4.
In the step for significant voxel selection, the threshold ts was selected from the group {0.5, 0.55, 0.6, 0.65} to 
determine a set of significant voxels. Generally, the number of significant voxels is reduced when the threshold ts 
is increased. However, few significant voxels were left when ts > 0.7 was considered in our experiment. Therefore, 
the maximum value of ts selected was 0.65 to reserve the useful information for the following classification step. 
Additionally, the threshold th and patch size w were set to 0.5 and 5, respectively. Table 5 shows the classification 
results with different ts values. This table also shows that ACC is improved by the increase in ts. In addition, all 
classification measurements reached their highest values when ts = 0.65. Thus, the threshold ts was fixed at 0.65 in 
the subsequent experiments to reduce the feature dimensionality and reserve useful information for the following 
classification step.
In the hierarchical classification step, the threshold th and patch size w are two crucial parameters that should 
be carefully determined. Thus, the two experiments were conducted to optimize the threshold th and patch size 
w, separately, during classification. In the first experiment, the proposed method was tested with different th val-
ues from 0 to 0.65. Moreover, the threshold ts and patch size w were set to 0.65 and 5, respectively. Table 6 shows 
that the classification results with the threshold th = 0.5 were higher than the classification results without the 
threshold (th = 0). However, the classification accuracy was reduced when the threshold th increased at th > 0.5. A 
threshold of th = 0.5 was chosen for the subsequent experiments. In the second experiment, the patch size w was 
varied from 1 to 3, 5, 7, 9, and 11 to test the classification performance with these different values. In addition, the 
thresholds ts and th were set to 0.65 and 0.5, respectively. As shown in Table 7, the ACC was improved by increas-
ing w from 0 to 5, but further increasing the patch size to 7, 9, and 11 reduced ACC. Therefore, the patch size w 
was fixed at 5 for the subsequent experiments.
Effectiveness of the use of longitudinal data. To assess the effectiveness of the use of longitudinal data, 
the classification performance was evaluated with MRI scans of MCI subjects from the baseline visit data and the 
longitudinal data. In the experiment for baseline visit data, only the baseline visit data were used for comparison 
in the significant voxel selection and hierarchical classification steps. For fair comparison, we also used two nested 
cross-validation loops (10-fold for each loop) to carefully select the parameters with optimal performance for the 
baseline visit data. Moreover, the parameters ts, th, and w were set to 0.65, 0.5, and 5, respectively, in accordance 
with the proposed method by using longitudinal data. The classification results of the proposed method with the 
baseline visit data and longitudinal data are shown in Table 8 and Fig. 3(a). The proposed method with longitudi-
nal data consistently outperforms the proposed method that used baseline data in terms of ACC, SEN, SPE, and 
AUC. High SEN values indicated high confidence in AD prediction, which will significantly benefit the applica-
tion of the method in real-life situations. The proposed method with longitudinal data significantly improved the 
sensitivity value (nearly 17% higher than the proposed method with baseline data). This high sensitivity may be 
advantageous for confident AD prediction and useful in practical applications.
Effectiveness of the hierarchical classification framework. To evaluate the effect of the hierarchical 
classification framework on the classification performance, we compared the obtained classification results by 
building a single global classifier and a hierarchical classification framework. For fair comparison, both classifi-
cation methods were used on the same significant voxel set. We then used an LRC and the proposed hierarchical 
classification framework, respectively, to achieve the final classification result. Moreover, the parameters ts, th, and 
w were set to 0.65, 0.5, and 5, respectively, in the proposed hierarchical classification method. Table 9 shows the 
classification results with respect to the single global classifier and the hierarchical classification framework. In 
addition, the ROC curves of different methods for classification of MCInc versus MCIc are illustrated in Fig. 3(b). 
These results demonstrate that the hierarchical classification framework performs better than the single classifier.
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Computation cost. In this study, the experiments were implemented on a standard PC with an Intel Xeon 
E5-2620 v3 processor at 2.40 GHz. To classify a subject in the testing step, the processing time was approximately 
5 min; of which, 4 min was allotted for intensity and spatial normalization, and 1 min was allotted for the actual 
classification. In the training step, 6 threads were used to perform voxel selection and hierarchical classifier learn-
ing, the parameters ts, th, and w were set to 0.65, 0.5, and 5, respectively. The total processing time for 118 MCI 
subjects was approximately 10 h; of which, 8 h was allotted for voxel selection, and 2 h was allotted for hierarchical 
classifier learning.
Discussion
We proposed a novel classification method for AD prediction. Our study is twofold. First, we investigated the 
longitudinal images of 131 individuals with MCI to obtain important information on the longitudinal change. 
The data were subsequently used to classify MCI subjects into either MCIc or MCInc. The longitudinal change 
is a crucial factor in the prediction of possible conversion from MCI to AD. This factor is widely used in AD 
conversion analysis20,23,38. In most methods, the selected time points of MRI scans must be the same among indi-
viduals to capture changes in the longitudinal data. However, given that a longitudinal study in the field of health 
sciences commonly covers a relatively long period of time, some individuals may miss their scheduled visits19. 
Therefore, the same time points of MRI scans are difficult to implement across individuals. In the present study, 
the voxel intensities in the MRI images from the longitudinal data were used as features. The MRI data gathered 
before the missing time point were used as the missing data. Thus, we could use the longitudinal data at different 
time points. Second, we developed a hierarchical classification framework to address the high feature dimen-
sionality issue and incorporate spatial information, thereby improving the classification accuracy. Unlike other 
hierarchical classification methods16,30, our proposed strategy established multiple and multilevel classifiers with 
supervised learning and suitable thresholds to address the issues of high feature dimensionality and sensitivity 
to small changes. These characteristics enhance the classification accuracy. In the experiment, the classification 
results with a threshold th are consistently higher than the classification results without this threshold (Table 6). 
Therefore, unusable information can be discarded through the proposed hierarchical classification method with 
a suitable threshold.
In the hierarchical classification framework, the patch size w was adjusted to optimize the classification perfor-
mance. Small patches may lack the required information for good performance in patch-level classification, and 
Parameter Description Setting
ts
Threshold in significant voxel 
selection 0.65
th
Threshold in hierarchical 
classification framework 0.5
w Patch size (w × w × w) 5
Table 4.  Summary of the parameter settings in the proposed method for AD prediction.
ts 0.5 0.55 0.6 0.65
ACC (%) 55.1 56.3 62.1 79.3
SEN (%) 62.0 67.6 64.2 87.7
SPE (%) 55.9 45.3 51.4 73.1
Table 5.  Classification results of the proposed method with different ts values.
th 0 0.5 0.55 0.6 0.65
ACC (%) 73.8 79.3 74.6 78.0 76.5
SEN (%) 83.8 87.7 85.0 84.1 83.8
SPE (%) 62.3 73.1 62.7 71.1 68.7
Table 6.  Classification results of the proposed method with different th values.
w 1 3 5 7 9 11
ACC (%) 74.0 74.0 79.3 76.3 76.3 74.8
SEN (%) 86.8 79.7 87.7 86.2 90.2 92.8
SPE (%) 65.1 69.2 73.1 69.0 63.2 49.3
Table 7.  Classification results of the proposed method with different w values.
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numerous patches or patch-level classifiers will significantly increase the computational cost for the classification. 
More redundant or even confounding information may be included in a large patch, thereby affecting the local-
ization of informative brain regions and the ensemble classification results. In our experiment, the classification 
results with w = 5 were higher than those of other patch sizes (Table 7). Therefore, a moderate-sized patch was 
optimum in the proposed method as compared with other patch sizes.
Comparisons of baseline visit data versus longitudinal data and single classifier versus hierarchical classifica-
tion were conducted to evaluate the performance of the proposed method in this study. Table 8 and Fig. 3(a) show 
that the classification results from longitudinal data are higher than those obtained with baseline visit data. These 
findings suggest that longitudinal change is a crucial factor for the prediction of future conversion of MCI to AD. 
Moreover, our experimental results show that the method with the hierarchical classification framework performs 
better than a single global classifier, probably because the hierarchical classification framework can better utilize 
local features and classifier decisions. In the hierarchical classification framework, the local spatial contiguity of 
image features is important during classification with a hierarchical spatial structure built from voxels to larger brain 
regions. The hierarchical spatial structure can utilize the local information better than the ROI-based methods30. 
An ensemble method can also improve the generalizability and robustness of individual classifiers for better 
classification decisions as compared with individual classifiers2. Therefore, the proposed hierarchical ensemble 
method can utilize the local features and make better classifier decisions than a single global classifier.
In the training stage, the proposed method requires that a classifier is trained for each voxel in the brain to 
select significant voxels and construct a hierarchical classification framework to train a hierarchical classifier. 
These two steps are off-line procedures; thus, each step is performed only once but used for all testing images. 
Moreover, both steps were run in multi-threads in this study, thereby significantly decreasing processing time.
Table 10 shows that the classification results of the proposed method (ACC = 79.4%, SEN = 86.5%) are com-
parable to the results of recently published papers. Tang et al.39 and Wee et al.40 extracted vertex-based features 
from MRI scans obtained from baseline visit data to classify MCI subjects into either MCIc or MCInc, and an 
accuracy of 75.0% and 75.1% were obtained, respectively. Liu et al.30 proposed a hierarchical ensemble classifica-
tion method to combine multilevel classifiers through gradual integration of a large number of features from local 
brain and interbrain regions. MRI scans from baseline visit data were used for AD prediction, and an accuracy of 
64.8% was attained. Suk et al.16 first used the deep learning method to learn a high-level latent and shared feature 
representation. They then constructed a hierarchical classifier for the classification of MCIc versus MCInc. MRI 
and PET markers were included, and an accuracy of 75.9% was obtained. Zhang et al.3 used longitudinal data to 
Method ACC (%) SEN (%) SPE (%) AUC
Baseline visit 71.7 69.9 77.7 0.754
Longitudinal data 79.4 86.5 78.2 0.812
Table 8.  Classification results of the proposed method with baseline visit data and longitudinal data.
Figure 3. ROC curves for the classification of MCIc and MCInc obtained with (a) baseline visit data and 
longitudinal data and (b) a single classifier and hierarchical classification.
Method ACC (%) SEN (%) SPE (%) AUC
Single classifier 64.9 54.9 78.0 0.712
Hierarchical classification 79.4 86.5 78.2 0.812
Table 9.  Comparison of single classifier and hierarchical classification for MCInc versus MCIc 
classification.
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predict future conversion of patients with MCI, and an accuracy of 78.4% was obtained. Recently, Korolev et al.41 
incorporated risk factors, cognitive and functional assessments, MRI, and plasma proteomic data for AD predic-
tion. They obtained a high accuracy of 80.0%. Although the accuracy of our study is less than that of Korolev et al.’s 
study, our study is comparable to their model that incorporated only MRI data (ACC = 71.4%). Therefore, 
incorporating many data sources can potentially improve our prediction model in the future. However, only the 
results of different methods in literature are listed. Direct comparison of the performances of different methods 
is not reasonable because various datasets and methods for extracting features and building classifiers were used. 
Nonetheless, the proposed method showed the highest sensitivity and the second highest accuracy among the 
methods for MCInc/MCIc classification. These observations implied that the proposed method can potentially 
enhance confidence in AD prediction.
In this research, only MRI data were used. The data can be expanded to include other image modality data 
in future studies. Different image modalities can provide complementary information for disease diagnosis. 
Moreover, other data sources, such as clinical scores, genetic data, and demographic data, can be included to 
improve our prediction model in the future. Further advanced classifier ensemble methods, such as sparse mul-
tiple kernel learning42, can be investigated in future work to improve the classification performance. Finally, our 
method exclusively focused on the MCIc/MCInc classification. In the future, we aim to incorporate clinical scores, 
such as the Alzheimer’s Disease Assessment Scale-Cognitive subscale and the Mini-Mental State Examination, to 
construct a joint regression and classification model. For instance, we can simultaneously perform AD and clin-
ical score prediction with such a model. Furthermore, we can estimate the time when an MCIc subject develops 
AD by using the longitudinal data and the constructed model (Δ t shown in Fig. 4).
Conclusion
This study presented a novel AD prediction method based on LMHC. Longitudinal images from individuals 
with MCI were investigated to obtain important information on the longitudinal changes for classifying MCI 
subjects into MCIc and MCInc. A hierarchical framework was introduced into the classifier to address the high 
feature dimensionality and incorporate spatial information for improved prediction accuracy. The performance 
of the proposed AD prediction method was tested on 131 patients with MCI with MRI scans at different time 
points. Our experimental results showed that longitudinal data and the hierarchical classification framework of 
our proposed method can improve the classification performance. To our knowledge, previous studies have not 
combined these two characteristics for AD prediction.
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